A WORLD-CLASS LINE-UP

As partner of our Life Sciences practice, Fabien Roy focuses his practice at Hogan Lovells on advising clients on European Union (EU) and national regulatory matters involving medical devices and pharmaceutical laws and guidelines. Fabien follows the new regulations on medical devices (MDR and IVDR) and the GDPR very closely and regularly advises clients on the requirements applicable to their digital health technologies. With a practice entirely focusing on complex regulatory issues faced by Life Sciences clients, he can quickly address and anticipate complex challenges and propose innovative solutions enabling clients to focus on their business.

Felix Georg Müller is experienced in production engineering, data science and business development. He is specialized in time series analysis and behavioural models for machines and plants. Before founding plus10 he was Fraunhofer group leader for autonomous production optimization. At plus10 he is responsible for business development, product market fit and sales.

With 25+ years of commercial and technical experience in primary pharmaceutical packaging and medical devices, I am now commercialising a variety of new applications for DuoVIAL® across a range of markets.  With packaging sustainability foremost, I'm excited by the advantages this format brings in terms of recyclability, minimal materials utilisation and refill cartridge based approach.A minimalist design capitalising on the latest laser technologies for a light touch carbon footprint.

Gemma Budd is Business Development Director for Nanopharm, an Aptar Company, where she is primarily responsible for developing business and collaborative opportunities for Aptar Pharma’s services, solutions and technologies in the orally inhaled and nasal drug product (OINDP) sector. With a university degree in Biomedical Sciences, Gemma has over 10 years of experience in the pharmaceutical industry in both research and commercial positions, from materials science and analytical services, to formulation technology and drug delivery devices, primarily for oral and inhaled dosage forms.

Holger Krenz, Vice President Applications Development Europe, at SiO2 Material Science, is together with his team responsible for the European customer activities to support the commercialization of SiO2´s product portfolio. He holds a diploma in biology with a focus on Neurophysiology. Holger is working for more than 20 years in the medical device industry in various positions including R&D project management, Marketing & Sales as well as Business Development at different companies e.g. Boehringer Ingelheim and WestRock / Silgan Dispensing. In 2014 he joined SiO2 Material Science.

Irving Paz Chagoya is Covestro´s Healthcare Segment Manager for EMEA. In this role he oversees the Industrial Marketing Strategy in the EMEA Healthcare plastics Industry for Covestro Polycarbonate Materials. Irving has more than 10 years of experience in the Healthcare Industry, serving in various roles for fortune 500 companies in technical marketing, business development and strategic management roles. Irving earned his MSc degree from the University of Warwick.

Sustainability Manager at Amcor Flexibles Europe Middle East and Africa, Isabelle JENNY holds an engineer degree in polymer and a PhD in Polymer Chemistry.She has been with Amcor since 2003 as a packaging development engineer and then as sustainability manager. Isabelle has more than 15 years’ experience in life cycle assessment and eco-design study in the food, pharmaceutical and medical flexible packaging market.She has also an expertise in sustainable sourcing, on biodegradable and compostable packaging and on flexible packaging recyclability.She is involved in the several EU initiatives like:
- HPRC (Healthcare Plastic Recycling Council): https://www.hprc.org 
- CEFLEX (A Circular Economy for Flexible Packaging): https://ceflex.eu/ 
- RECYCLASS: https://recyclass.eu/ 
- MULTICYCLE project: http://multicycle-project.eu/
- PEFCR (Product Environmental Footprint Category Rules for Flexible Packaging: https://ec.europa.eu/environment/eussd/smgp/ef_transition.htm 
- ASI (Aluminium Stewardship Initiative): https://aluminium-stewardship.org/

Juha Mattila is Director, Sterilization Technologies, responsible for the STERIS Life Sciences Finland GMP products portfolio. He has B. Sc. in HVAC and Process Engineering, and M. Eng. in Business Informatics. He has over 22 years of experience with pharmaceutical and research technologies, including R&D, engineering, and product management. He is an active member of PDA, ISPE and Finnish Biosafety Network and collaborating as subject matter expert in relative international standard work groups, representing Finland.

Katsuyuki Takeuchi is Associate Product Manager at Terumo Pharmaceutical Solutions. With extensive knowledge in pharmaceutical science, he has worked in research and development of injectable drug products such as IV solution bags and prefilled syringes, and contributed to launch various products into the market. Utilizing his experience, Mr. Takeuchi currently has product management responsibilities for the polymer based prefillable syringes platform.

Klaus Heinisch has been an expert in the production and distribution of secondary packaging since 2000, first at Arthur Theis GmbH Wuppertal and later at Edelmann GmbH in Heidenheim an der Brenz. Klaus has held various positions in technical project management and quality management at different locations. He currently supports and advises international key accounts within the framework of Key Account Management Pharma.  The main topics of counterfeit protection and serialisation also fall within his area of expertise.

Laurent TONNELIER is an expert on Automatic Identification and Data Capture, and Security at AFNOR, member of ISO. He is involved in several Working Groups at GS1. He is co-founder of XTAG, an innovative software solution to connect patients through objects, using optical identification systems. XTAG, Medicine Labelling for visually impaired, was awarded Best project by HEC Challenge+ in 2020.

As Director for Technical Support Europe, Marc and his team are responsible to assure the outstanding science based technical service to pharmaceutical customers on West´s products. Marc is working almost 20 years in the life science and pharmaceutical industry in various R&D and customer facing manager positions. He published more than 30 articles and patents and holding a PhD in chemistry.

Marcus Bates is Vice President, Digital Health at Aptar Pharma.  Marcus has spent more than 20 years working in the world of drug delivery devices and connected health. In this time he has worked for two of the industry leading companies, in a range of roles, spending the majority of his time at Aptar.  Marcus is responsible for the business development activities in Europe and working closely with the sales and engineering teams supporting growth and new product development.

Mayur is an accomplished leader with over 18 years of innovative pharma digital health and medical device development experience. He advises pharmaceutical companies on digital health innovation, technology strategy, product development, regulatory and commercialisation aspects. Mayur has led a wide range of development programmes in PA and his past employments. He has a strong track record in leading development of innovative devices and techniques. Mayur has helped PA’s clients to address some of the most stringent technical needs and challenges.

Michael Earl joined Owen Mumford as Director of Pharmaceutical Services in November 2020. He was previously the Commercial VP at Bespak, leading the commercial team there to drive growth in their substantial medical devices business. Prior to that, he worked for a number of pharma, biotech and device companies. In a career spanning 35 years, he has been responsible for all aspects and stages of drug and device development and commercialisation. Michael has also completed a substantial number of commercial, licensing and M&A transactions. 

Noel Gibbons BSc (Hons) is the Technical Advisor for Medical Device and Pharmaceutical packaging within STERIS AST. He has significant experience in a wide variety of areas from manufacturing, process validation, package testing, packaging process validation, package integrity testing, quality and international test standards. He has considerable practical experience in medical device packaging at all levels, including evaluation of proposed packaging and current packaging designs and related validation documentation. 
Noel has presented nationally and internationally on Medical Device and Pharmaceutical package testing particularly on the requirements of the ISO11607 and associated test standards. He is a featured speaker at international conferences and seminars on medical and pharmaceutical packaging aspects.

Oli Gould is an experienced Design Manager with a background in engineering and 10 years working in medical device development, preceded by several years working with household consumer technology brands. As R&D Design Team Manager at Owen Mumford, Oli supports the development of innovative new medical devices. Alongside a range of competences, Oli specialises in engineering analysis and environmental sustainability in product development.

Olivia is a Business Development Manager within Owen Mumford Pharmaceutical Services, and is responsible for defining strategic goals and delivering commercial plans for our self-injection platforms. As a commercial leader, Olivia offers a wealth of knowledge and experience in the development of injectable devices and building partnerships with global pharmaceutical and biotech companies.

After his bachelor study in Business Administration and International Business, Patrick focused on the topics energy and sustainability in his masters studies.After some time at one of the worlds leading energy companies “Engie”, Patrick joined Drees & Sommer, a mix between project management office, engineering service provider as well as consultancy, and dealt as team leader with the development of holistic energy and sustainability concepts for big real estate, industrial sites up to city districts.Since mid of the year 2021 he works as “Global Sustainability Manager” responsible for the SUS strategy and road mapping as well as value-chain comprising collaboration for our moulded glass business as most energy and resource intense business within Gerresheimer.

Peter began his career in the early 1980’s selling various types of polymeric rawmaterials (film, sheet, and synthetic resin) to the medical, pharmaceutical andelectronics industries in Puerto Rico and throughout the Caribbean.Polymerland, General Electric Plastics’ resin distributor, acquired the companyhe co-founded and expanded sales to include Mexico and Central America.In 1994 Peter joined American Mirrex (a major supplier of PVC film to thehealthcare industry) as Product Manager and later Director of Marketing.In 1996, he founded Montesino Associates, providing consulting and advisoryservices to the healthcare packaging industry. In 2000, he founded MontesinoTechnologies, a manufacturers’ representative for high technology film andconverting equipment, specifically calenders and accessories for PVC andrubber.Over the next decade Montesino grew as a thought leader in healthcarepackaging, managing projects regulatory change (DMFs, interchangeability, andQbD in packaging); technological change (FEA, simulation, 3D tools, etc.),partnering with customers to manage and thrive in the rapidly changingchannels for packaging in the healthcare marketplace. Montesino’s presence inLatin America grew as well, leading the introduction and surprising growth ofhigh barrier materials in the midst of challenging times.Peter continues to lead Montesino in new challenges: Single Use Systems inbiopharmaceuticals, sustainability in packaging, the emerging Cannabis market,assisting suppliers and end users in understanding and reaping benefits fromchanges in healthcare packaging. Exploring emerging markets and packaging’srole in their growth remains an ongoing focus.

MASTER of Science (M2) in Nuclear Enginerring.

Since 01.2019: Validation Manager at STERIS Daeniken Switzerland:

X-Ray Radiation Technical Center (RTC) Manager for Europe and Asia
Management of the site Validation Team and Laboratory
Member of STERIS Daeniken Executive Board (Geschäftsleiter)
Radiation Protection Officier
Radiation Technical Support and Guidance for Gamma and X-Ray Sterilisation Processes
Performance Qualification - Dose Mapping according to GMP, ISO 11137 and AAMI TIR 29 Standards
Performing of Alanine Dosimetry System qualification, calibration and maintenance activities
Technology Deployment and Innovation in Radiation Technical Team

Dr. Christiaens received his PhD from the Analytical Chemistry Department of the University of Leuven (Belgium) in 1991. From 1992 to 1997, he was the Lab Manager in two CROs.After, he joined Shell Chemical Company in Houston (US), as an independent consultant, working on hydrogenated triblock co-polymers. Since 2001, Piet has held the position of Scientific Director at Nelson Labs Europe where he develops analytical methodsand protocols for both extractables and leachables studies for thepharmaceutical and medical industries.Dr. Christiaens oversees all laboratory operations at Nelson Labs Europe and supports business development and R&D.

Rob is an engineer in the R&D department based in Woodstock (UK) and predominately works on Autoinjector projects including the Aidaptus platform device.  Rob’s specific areas of interests include mechanical design of mechanisms, complete platform device tolerance analysis and CT scanning for metrology and full device assessment.  Prior to working at Owen Mumford Rob has worked in the fields of Product Testing & Certification and Healthcare facility provision.Rob holds BEng(Hons) and MSc degrees in mechanical engineering.

Rob Schultheis, Founder & Chief Technology Officer ZebraSci

Rob founded ZebraSci in 2009 as a company dedicated developing novel inspection technologies to ensure quality in parenteral packaging and combination products.As Chief Technology Officer, Rob oversees all aspects of the ZebraSci technology pipeline.
Rob holds a Master of Science degree in Mechanical Engineering and Mechanics from the Drexel University.
Prior to ZebraSci, Rob has been working in various senior engineering positions for Amgen and Merck.

Roberto Valenti is Head of Materials Development in Bormioli Pharma. He has been in charge since January 1999 of the R&D activities aimed at the use and validation of innovative materials, such as more sustainable plastics - recycled, bio-based, compostable - or barrier materials aimed at improving the container performances. Roberto Valenti is constantly updated on the latest developments through a consolidated network of partners and suppliers, supporting clients on their materials innovation projects.

Robert Lindner is working for SCHOTT Pharmaceutical Systems as Global Product Manager adaptiQ®. In this role he is responsible for SCHOTT’s ready-to-use vials portfolio, which is part of the SCHOTT iQ® platform.

Besides that he works on bringing additional value to pharma companies with novel secondary packaging solutions for the whole SCHOTT iQ® platform. He has working experience in managing international R&D projects and technology networks, both in plastics processing and functional thin-films for medical and electronic applications. Robert Lindner holds a PhD in Physical Chemistry from Mainz University.

I graduated in Agronomy Engineering at Montpellier SupAgro. I started my career in the food industry, working in Environmental Services.

I joined Adelphe in July 2020 as a Key Account Manager. My mission is to support companies, mainly in the pharmaceutical sector, around 3 main themes: simplification of administrative procedures, eco-design of packaging and support for companies in their CSR strategy.

Ross is an educator, editor, and pharmaceutical segment leader with over 17 years of global industry experience. To his credit he has successfully founded and led two biomedical ventures through to acquisition: BioFaran SA and Eulysis UK Limited. With funding and endorsement from the World Health Organization, Bill & Melinda Gates Foundation, HRH Prince Charles’ Prince’s Trust, and the Royal Society of Edinburgh, he developed a drug delivery system that enabled twice as many medicines to be produced, transported, stored, and delivered at half the cost worldwide. As a published author and speaker Ross has been featured in Forbes magazine, Bloomberg Economic News, and as a guest of the BBC, and World Health Organization.Ross supports customers through strategy implementation and execution, providing solutions to help avoid quality performance issues and product recalls. He is a committee participant on the World Health Organization Medical Device Unit and the American Association of Pharmaceutical Scientists.

As Business Development Manager and member of the Owen Mumford Leadership team, Sian is responsible for leading and delivering the strategic and tactical commercial business development plan of Owen Mumford’s new and existing platform injectable drug delivery devices.  Sian has in-depth technical knowledge of medical devices with core expertise in self-injection- auto-injectors, pens and safety syringes with pre-fillable syringes and primary drug containers for injectable drugs.

Stefan Lutzmayer is a Consultant within the EMEA Thought Leadership based out of Vienna. He analyses IQVIA’s data assets to gain valuable insights for our customers on a broad range of topics, including cell, gene and RNA therapies, biosimilars and launch performance.
Stefan has prior experience working as an IT consultant to the Healthcare and Life Sciences industry. He is trained in molecular biology and data analysis and has published multiple peer-reviewed articles in internationally-renown journals. Stefan holds a PhD degree in Life Sciences from the University of Vienna.

Thomas is an electronics and software engineer at Team Consulting, where he specialises in embedded software development for medical devices. Before joining Team, Thomas worked for SLE in London; a company focusing on neonatal ventilator systems. He has an MEng in Biomedical Engineering from Imperial College London.

Thomas is a successful life science corporate finance advisor, capital sourcing expert, investor and mentor. With his large network and long-standing experience in working with Life Sciences companies he’s a trusted partner to his clients. Building bridges between company owners as well as start-ups and investors, constructing compelling equity stories, deal moderation and negotiation are his speciality.

Tom leads engineering and scientific teams developing new injection devices, pumps and inhalers.  He has been the named inventor on dozens of patents throughout his 20+ years’ experience in industry.
He is a regular speaker at various international conferences on innovation and medical device development, and mentors Engineering and MBA students at the Cambridge University Engineering Department and the Judge Business School.
He read Engineering at Cambridge University before becoming the Choate Fellow in Human Physiology and Pathology at Harvard University.

Tom studied chemical engineering in Antwerp and completed his education with a MBA from the university of Sankt Gallen.After working in the chemical and pharmaceutical sector in Belgium for 3 years he joined SCHOTT in 2008.After different positions in the pharmaceutical product development department he became part of the product management team with focus on the SCHOTT TOPPAC® brand. In this role he works on the strategic orientation and innovation pipeline of the product group.

Mr. Tomer El-Gad has global responsibility for the business development of West’s Combination Products Solutions. In this role, he leads a team to closely work with customers to understand their combination products needs and to develop collaboration agreements to support their projects throughout all facets from cradle to grave. Mr. El-Gad has eighteen years of experience in medical device design & development, high volume manufacturing, and global product launches. He joined West in 2012, following seven years with Teva Pharmaceutical Industries Ltd., where he held broad responsibilities for the Self Injection Systems of the branded products. He has a BSc in Industrial Engineering (with honors) and an MBA, both from Tel Aviv University, Israel.